Have the recently completed phase III trials significantly impacted adjuvant treatment choices for stage II breast carcinoma?

E. Middleman^*, M. P. Castro, W. Gradishar, M. J. Kane

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	xvi-xxi
Journal	Seminars in Oncology
Volume	26
Issue number	4
State	Published - 1999

ASJC Scopus subject areas

Hematology
Oncology

Other files and links

Cite this

@article{d7b71d7a47064edda37a86624e30a6f1,

title = "Have the recently completed phase III trials significantly impacted adjuvant treatment choices for stage II breast carcinoma?",

author = "E. Middleman and Castro, {M. P.} and W. Gradishar and Kane, {M. J.}",

year = "1999",

language = "English (US)",

volume = "26",

pages = "xvi--xxi",

journal = "Seminars in Oncology",

issn = "0093-7754",

publisher = "W.B. Saunders",

number = "4",

}

TY - JOUR

T1 - Have the recently completed phase III trials significantly impacted adjuvant treatment choices for stage II breast carcinoma?

AU - Middleman, E.

AU - Castro, M. P.

AU - Gradishar, W.

AU - Kane, M. J.

PY - 1999

Y1 - 1999

UR - http://www.scopus.com/inward/record.url?scp=0032851671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032851671&partnerID=8YFLogxK

M3 - Review article

C2 - 10482178

AN - SCOPUS:0032851671

SN - 0093-7754

VL - 26

SP - xvi-xxi

JO - Seminars in Oncology

JF - Seminars in Oncology

IS - 4

ER -